SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SNRS- Sunrise Technologies
SNRS 0.0000010000.0%Jun 6 11:01 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Double E who wrote (2859)7/26/1999 11:43:00 AM
From: BARRY ALLEN  Read Replies (2) of 4140
 
Hopefully all the selling is over.

On Friday, trading 27 million shares, everyone who wanted out, got out. Today, all the margin calls hit and forced more people to sell. So far 9 million shares traded. SNRS has almost turned the float, which at this point is good.

Now, let the buying begin and let the price get back to where this company is really worth. IMHO, $5-6 short term (this week) and $8-9 intermediate term (30 days). SNRS is way oversold at this point.

LTK works and will eventually be approved. Sometimes new technology is kept from rapidly being brought to the marketplace because of poor education of the people making these decisions. Unfortunately, the company and shareholders did not foresee this.

Below is a buy rec. put out on SNRS this morning!

Sunrise Technologies - Sunrise got creamed on Friday after an FDA advisory committee voted to not approve the company's laser thermal keratoplasty system used for treating farsightedness. However, the product is currently used across the world, and the CEO feels confident that with more data, Sunrise will eventually convince the FDA to approve the treatment for the United States.
dartz.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext